Social Determinants of Racial and Ethnic Disparities in Cutaneous Melanoma Outcomes

the ONA take:

Poor prognosis and limited treatment options for advanced-stage cutaneous melanoma make early detection and diagnosis critical. Although its incidence is greatest in whites, most studies have shown that racial and ethnic minorities with a diagnosis of cutaneous melanoma are more likely to experience worse outcomes. In general, patients’ perception of their risk of cancer is a significant barrier to risk reduction. The medical literature has shown that blacks and Hispanics perceive their risk for developing skin cancer as very low. Therefore, these patient populations are not likely to practice skin self-examinations. As a result, they are more likely to present with advanced disease at diagnosis than are whites.

Socioeconomic status measures (eg, highest level of education, occupation, income, health insurance status, and place of residence) are key factors in preventive medicine practices, cutaneous melanoma incidence, stage at diagnosis, and melanoma mortality rates. Furthermore, acculturation, the process by which immigrants adopt the lifestyle norms of their host country, among Hispanics has contributed to behavioral changes that increase their risk of skin cancer.

With this information, the medical community will be able to develop more effective programs targeted to these populations. However, more information is needed about this disease in regard to other US minority groups, such as Asians, Pacific Islanders, Native Americans, and Native Alaskans.

Cancer Control
Cancer Control

Background: This article sought to elucidate how aspects of poverty and culture may contribute to race- and ethnicity-based disparities in cutaneous melanoma outcomes.

Methods: We identified published studies addressing the social determinants of melanoma. Selected review articles included US-based studies comprised of patients representing adults, children, and adolescents.

Results: African Americans and Hispanics diagnosed with cutaneous melanoma are more likely to present with more advanced stages of disease at diagnosis and have higher rates of mortality than their nonminority counterparts. These disparities may be a consequence of economic, social, and cultural barriers such as low income, public forms of health insurance, lower levels of education, lower levels of melanoma awareness and knowledge, and lower rates of participation in melanoma screening. No studies in the literature examined the potential impact of social injustice, English proficiency, immigrant status, and health literacy.

Conclusions: Substantial gaps exist in our knowledge of the pathways linking social determinants and race- and ethnicity-based disparities in melanoma. More studies are warranted to inform the development of effective interventions aimed at narrowing inequities and improving cutaneous melanoma outcomes among minority populations.


Cutaneous melanoma is a significant public health con­cern. In 2013, 76,690 incident cases and 9,480 deaths occurred from cutaneous melanoma in the United States alone.1 The poor prognosis and limited treatment options of advanced-stage disease make early detec­tion and diagnosis critical. Although the incidence of cutaneous melanoma is greatest in Caucasians,2 most studies have shown that racial and ethnic minorities diagnosed with cutaneous melanoma are more likely to experience worse cutaneous melanoma outcomes.2-7

Surveillance, Epidemiology, and End Results data reveal that Hispanics, African Americans, Amer­ican Indians, and Asians diagnosed with cutaneous melanoma are more likely to present with advanced (regional and metastatic) cutaneous melanoma than Caucasians.3,4,8-12 Moreover, while the proportions of local stage or in situ cutaneous melanomas have in­creased among Caucasians, an opposing trend has been observed among Hispanic men living in Cal­ifornia who present with thicker primary tumors at diagnosis.4 Evidence also suggests variability in the quality of care received by minority patients with cu­taneous melanoma. A Surveillance, Epidemiology, and End Results–based study found that blacks were less likely than Caucasians to receive surgical treatment for melanoma,13 and those who underwent surgery experienced shorter survival time than other races.13

After accounting for demographical and clini­cal characteristics, minorities have an approximate two- to three-fold greater risk of melanoma-specific mortality than their nonminority counterparts.14 In Af­rican Americans, differences in mortality rates persist even after stage at diagnosis is considered.2 Although biological factors may account for some of these dif­ferences (cutaneous melanomas in minorities tend to occur at unusual anatomical sites and may be of more aggressive histological subtypes), the underly­ing mechanisms of these disparities remain unclear.2  

Page 1 of 5
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs